| Annual Financials | 2020 | 2021 | 2022 | TTM |
Revenue  | 216 | 249 | 342 | 0 |
| Expenses | 176 | 194 | 264 | 0 |
| EBITDA | 40 | 55 | 79 | 0 |
| Operating Profit % | 17 % | 20 % | 22 % | 0 % |
| Depreciation | 11 | 13 | 14 | 0 |
| Interest | 14 | 14 | 11 | 0 |
| Profit Before Tax | 15 | 29 | 54 | 0 |
| Tax | 4 | 8 | 12 | 0 |
| Net Profit | 11 | 21 | 42 | 0 |
| EPS in ₹ | 4.11 | 7.92 | 5.22 | 0.00 |
GPT Healthcare
GPT Healthcare
149.98
+2.78
(1.89%)
Market Cap
1,230.66 Cr
PE Ratio
25.82
Volume
2,08,974.00
Day High - Low
152.50 - 147.20
52W High-Low
185.00 - 115.00
There are new updates from the company1 day ago
View
Key Fundamentals
Market Cap
1,230.66 Cr
EPS
5.22
PE Ratio
25.82
PB Ratio
6.03
Book Value
32.83
EBITDA
78.80
Dividend Yield
2.67 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
26.34
Debt to Equity
0.76
Analyst Rating and Forecast
- By Refinitiv from1 analysts
Actual
Company News
View All News
GPT Healthcare Limited initiates the Second 100 Days Campaign 'Saksham Niveshak' to help shareholders claim unpaid dividends and update KYC details from April 1, 2026, to July 9, 2026.
GPT Healthcare Limited will hold an analyst and institutional investor meeting on June 11, 2026, as part of the InsightX 2026 Choice Virtual Conference.
GPT Healthcare Outlines FY27 Growth GuidanceMay 20, 2026
GPT Healthcare projects 15% revenue growth and ~20.2% EBITDA margin for FY27, with ARPOB rising ~8%, new hospital commissions, and occupancy targets across key units.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
8,524.00 | #1 1,22,562.04 | 59.98 | #1 25,228.50 | 14.70 | #1 2,032 | 33.00 | 68.87 | |
1,003.10 | 97,615.18 | 67.88 | 8,373.45 | 16.56 | 1,464 | 7.27 | 50.76 | |
989.75 | 74,721.98 | 70.07 | 9,127.84 | 16.28 | 1,064 | 44.26 | 65.13 | |
790.35 | 40,949.70 | 92.97 | 4,643.22 | 8.32 | 384 | #1 79.65 | 68.97 | |
1,934.30 | 39,529.51 | 48.69 | 7,896.04 | #1 41.63 | 788 | 13.53 | 55.99 | |
1,242.10 | 33,386.45 | 58.84 | 4,410.27 | 16.94 | 584 | 39.64 | 59.05 | |
781.60 | 31,274.86 | 132.33 | 3,904.60 | 27.31 | 198 | -68.80 | 58.50 | |
448.50 | 14,208.82 | 85.34 | 2,080.08 | 18.39 | 168 | 17.65 | 41.13 | |
1,326.70 | 13,473.85 | 48.26 | 1,703.08 | 8.69 | 262 | 38.41 | 50.60 | |
292.50 | 12,633.98 | #1 44.69 | 1,679.36 | 17.77 | 272 | 46.56 | 69.56 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
37.57 %
Net Income Growth
97.63 %
Cash Flow Change
53.50 %
ROE
67.13 %
ROCE
54.46 %
EBITDA Margin (Avg.)
3.97 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 |
| Total Assets | 309 | 317 | 323 |
| Fixed Assets | 226 | 220 | 220 |
| Current Assets | 63 | 86 | 86 |
| Capital Work in Progress | 2 | 0 | 1 |
| Investments | 1 | 1 | 10 |
| Other Assets | 80 | 97 | 92 |
| Total Equity & Liabilities | 309 | 317 | 323 |
| Current Liabilities | 65 | 60 | 69 |
| Non Current Liabilities | 117 | 123 | 97 |
| Total Equity | 127 | 134 | 158 |
| Reserve & Surplus | 69 | 76 | 78 |
| Share Capital | 18 | 18 | 80 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 |
| Net Cash Flow | -1 | 4 | 4 |
| Investing Activities | -54 | -17 | -5 |
| Operating Activities | 42 | 43 | 66 |
| Financing Activities | 12 | -22 | -57 |
Share Holding
| % Holding | Oct 2021 | Oct 2023 | Feb 2024 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 99.97 % | 67.34 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 6.68 % | 5.38 % | 4.70 % | 4.72 % | 4.48 % | 4.96 % | 3.20 % | 2.74 % | 2.81 % |
| DIIs | 0.00 % | 0.00 % | 10.07 % | 12.81 % | 13.08 % | 11.99 % | 11.30 % | 11.35 % | 9.32 % | 6.46 % | 6.20 % | 6.84 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 17.14 % | 12.16 % | 13.61 % | 15.07 % | 15.33 % | 15.55 % | 16.65 % | 18.89 % | 19.11 % | 18.33 % |
| Others | 0.03 % | 32.66 % | 7.22 % | 2.78 % | 2.35 % | 2.66 % | 3.08 % | 3.04 % | 3.50 % | 5.87 % | 6.38 % | 6.45 % |
| No of Share Holders | 9 | 9 | 9 | 76,664 | 71,293 | 74,737 | 70,147 | 68,365 | 67,060 | 67,617 | 66,626 | 64,075 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5 | 3.5 | 2.5 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.84 | 2.38 | 2.17 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 06 Aug 2026 |  Annual General Meeting | NA | 06 Aug 2026 | 141.65 | 147.20 |
| 30 Jul 2026 |  Dividend | ₹ 1.50 /share | 30 Jul 2026 | 141.65 | 147.20 |
| 02 Apr 2024 | Dividend | ₹ 1.00 /share | 02 Apr 2024 | 167.25 | 177.30 |
| 18 Jul 2024 | Dividend | ₹ 1.50 /share | 18 Jul 2024 | 162.50 | 170.95 |
| 25 Jul 2024 | Annual General Meeting | NA | 25 Jul 2024 | 162.50 | 167.99 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 173.64 | 163.54 |
| 28 Nov 2024 | Dividend | ₹ 1.00 /share | 28 Nov 2024 | 163.54 | 173.98 |
| 11 Feb 2025 | Quarterly Result Announcement | NA | 11 Feb 2025 | 178.93 | 161.60 |
| 23 May 2025 | Quarterly Result Announcement | NA | 23 May 2025 | 156.88 | 155.00 |
| 29 Jul 2025 | Dividend | ₹ 1.50 /share | 29 Jul 2025 | 155.00 | 159.63 |
| 05 Aug 2025 | Annual General Meeting | NA | 05 Aug 2025 | 155.00 | 183.40 |
| 06 Aug 2025 | Quarterly Result Announcement | NA | 06 Aug 2025 | 161.35 | 180.01 |
| 08 Nov 2025 | Quarterly Result Announcement | NA | 08 Nov 2025 | 149.82 | 147.35 |
| 14 Nov 2025 | Dividend | ₹ 1.00 /share | 14 Nov 2025 | 147.35 | 143.45 |
| 02 Feb 2026 | Quarterly Result Announcement | NA | 02 Feb 2026 | 129.40 | 128.80 |
| 18 May 2026 | Quarterly Result Announcement | NA | 18 May 2026 | 144.12 | 141.65 |
Announcements
Intimation Regarding Second 100 Days Campaign-Saksham Niveshak
1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation4 days ago
4 days agoCompliances-Reg.24(A)-Annual Secretarial ComplianceMay 26, 2026
May 26, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2026
May 23, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 22, 2026
May 22, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 20, 2026
May 20, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 19, 2026
May 19, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 18, 2026
May 18, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 18, 2026
May 18, 2026Corporate Action-Board approves DividendMay 18, 2026
May 18, 2026Corporate Action-Fixes Book Closure For 37Th Annual General MeetingMay 18, 2026
May 18, 2026Results-Financial Results For Q4FY202526May 18, 2026
May 18, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On May 18 2026May 18, 2026
May 18, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 11, 2026
May 11, 2026Board Meeting Intimation for Approval Of Audited Results And Recommendation Of Final Dividend If Any.May 11, 2026
May 11, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2026
Apr 10, 2026Announcement under Regulation 30 (LODR)-Change in ManagementApr 02, 2026
Apr 02, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 05, 2026
Mar 05, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 02, 2026
Mar 02, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 03, 2026
Feb 03, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 03, 2026
Feb 03, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 02, 2026
Feb 02, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 02, 2026
Feb 02, 2026Un-Audited Financial Results For The 3Rd Quarter And Nine Months (Q3 & 9MFY26) Ended December 31 2025Feb 02, 2026
Feb 02, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On February 2 2026Feb 02, 2026
Feb 02, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 27, 2026
Jan 27, 2026Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Along With Limited Review Report Of The Statutory Auditors Thereon Of The Company For The 3Rd Quarter And Nine Months (Q3 & 9MFY26) Ended December 31 2025.Jan 27, 2026
Jan 27, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Closure of Trading WindowDec 29, 2025
Dec 29, 2025Appointment Of MUFG Intime India Private Ltd For Providing Investor Relations Advisory Services.Dec 26, 2025
Dec 26, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 08, 2025
Nov 08, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 08, 2025
Nov 08, 2025Results-Unaudited Financial Results For The 2Nd Quarter And Half Year Ended September 30 2025.Nov 08, 2025
Nov 08, 2025Corporate Action- Board Fixes Record Date For Interim DividendNov 08, 2025
Nov 08, 2025Corporate Action-Board approves DividendNov 08, 2025
Nov 08, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On November 8 2025Nov 08, 2025
Nov 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 04, 2025
Nov 04, 2025Board Meeting Intimation for Considering Inter Alia And Approving The Unaudited Financial Results Of The Company For The 2Nd Quarter And Half Year Ended On September 30 2025 And To Declare Interim Dividend For The Financial Year 2025-26.Oct 31, 2025
Oct 31, 2025Appointment (Regularization) Of Mr. Shree Gopal Tantia Promoter (DIN:00001346) As Non-Executive Director Of The CompanyOct 29, 2025
Oct 29, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationOct 29, 2025
Oct 29, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportOct 29, 2025
Oct 29, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotOct 29, 2025
Oct 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 15, 2025
Oct 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 14, 2025
Oct 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 27, 2025
Sep 27, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Axis Balanced Advantage Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
Axis Multi Asset Allocation Direct Plan-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.00% | 0 | 0.00% | -0.03% | |
Bandhan Infrastructure Fund Direct Plan-Growth | 0.00% | 0 | 0.00% | -0.51% | |
Bandhan Retirement Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
Bandhan Small Cap Fund Direct-Growth | 0.00% | 0 | 0.00% | -0.18% | |
 Kotak Multi Asset Allocation Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 59.23
ATR(14)
Volatile 5.49
STOCH(9,6)
Neutral 69.68
STOCH RSI(14)
Neutral 66.70
MACD(12,26)
Bullish 0.53
ADX(14)
Strong Trend 33.15
UO(9)
Bearish 46.14
ROC(12)
Uptrend And Accelerating 3.73
WillR(14)
Neutral -50.29
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
